Back

Linking cellular lipid trafficking profiles of individuals to the outcomes of statin treatment in the general population

30 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Lipid metabolism, vascular function, and novel strategies in atherosclerosis prevention Lipid Metabolism, Metabolic Syndrome, Diabetes ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Simon Pfisterer

MONCYTE Health, Helsinki (Finland)

6 More presentations in this session

Presentation thumbnail
Adipose and non-adipose layers of epicardium: paracrine activity consequences on cardiomyocytes and modulation by semaglutide
Doctor S. Eiras (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Aging-associated loss of adipose tissue in modification of vascular function and metabolism
Doctor K. Yang (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Gut ismA-expressing bacteria mitigate atherosclerosis by modulating cholesterol metabolism
Doctor K. Shabanian (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
Association of HDL composition and functionality with markers of subclinical vascular disease in individuals with extremely high HDL
Mrs F. Juliani (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Time-restricted feeding attenuates intimal hyperplasia and modulates FGF21 signaling in a mouse model of carotid artery stenosis
Mr S. Zhao (Lausanne, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid metabolism, vascular function, and novel strategies in atherosclerosis prevention

The Event

Event poster

ESC Congress 2025

30 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Session
Lipids as biomarkers and treatment target
thumbnail
Congress Presentation
Lipid management in high cardiovascular risk patients without prior myocardial infarction or stroke - preliminary data from the VESALIUS-REAL global burden study
thumbnail
Congress Presentation
Unmet needs in lowering LDL-c: barriers to goal attainment and need for innovative targets

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources